PDB Short entry for 1LD5 HEADER HYDROLASE INHIBITOR 08-APR-02 1LD5 TITLE STRUCTURE OF BPTI MUTANT A16V COMPND MOL_ID: 1; COMPND 2 MOLECULE: PANCREATIC TRYPSIN INHIBITOR; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES; COMPND 5 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: BOS TAURUS; SOURCE 3 ORGANISM_COMMON: CATTLE; SOURCE 4 ORGANISM_TAXID: 9913; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21 (DE3) PLYSS; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PAED4 KEYWDS BPTI, KUNITZ FOLD, HYDROLASE INHIBITOR EXPDTA SOLUTION NMR NUMMDL 10 AUTHOR T.CIERPICKI,J.OTLEWSKI REVDAT 3 27-OCT-21 1LD5 1 REMARK SEQADV REVDAT 2 24-FEB-09 1LD5 1 VERSN REVDAT 1 11-SEP-02 1LD5 0 JRNL AUTH T.CIERPICKI,J.OTLEWSKI JRNL TITL NMR STRUCTURES OF TWO VARIANTS OF BOVINE PANCREATIC TRYPSIN JRNL TITL 2 INHIBITOR (BPTI) REVEAL UNEXPECTED INFLUENCE OF MUTATIONS ON JRNL TITL 3 PROTEIN STRUCTURE AND STABILITY. JRNL REF J.MOL.BIOL. V. 321 647 2002 JRNL REFN ISSN 0022-2836 JRNL PMID 12206780 JRNL DOI 10.1016/S0022-2836(02)00620-4 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH A.GRZESIAK,R.HELLAND,A.O.SMALAS,D.KROWARSCH,M.DADLEZ, REMARK 1 AUTH 2 J.OTLEWSKI REMARK 1 TITL SUBSTITUTIONS AT THE P1' POSITION IN BPTI STRONGLY AFFECT REMARK 1 TITL 2 THE ASSOCIATION ENERGY WITH SERINE PROTEINASES REMARK 1 REF J.MOL.BIOL. V. 301 205 2000 REMARK 1 REFN ISSN 0022-2836 REMARK 1 DOI 10.1006/JMBI.2000.3935 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : NMRPIPE 1.8, CNS 1.0 REMARK 3 AUTHORS : DELAGLIO, F.; GRZESIEK, S.; VUISTER, G.; ZHU, G.; REMARK 3 PFEIFER, J.; BAX, A. (NMRPIPE), BRUNGER, A.T.; REMARK 3 ADAMS, P.D.; CLORE, G.M.; DELANO, W.L., GROS,P.; REMARK 3 GROSSE-KUNSTLEVE, R.W.; JIANG, J.S.; KUSZEWSKI, J.; REMARK 3 NILGES, M.; PANNU, N.S.; READ, R.J.; RICE, L.M.; REMARK 3 SIMONSON, T.; WARREN, G.L. (CNS) REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1LD5 COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 10-APR-02. REMARK 100 THE DEPOSITION ID IS D_1000015851. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298 REMARK 210 PH : 3.1 REMARK 210 IONIC STRENGTH : 0 REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : 4MM BPTI_A16V REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D TOCSY; 2D NOESY REMARK 210 SPECTROMETER FIELD STRENGTH : 500 MHZ REMARK 210 SPECTROMETER MODEL : UNITYPLUS; DRX REMARK 210 SPECTROMETER MANUFACTURER : VARIAN; BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : SPARKY 3.95, DYANA 1.5 REMARK 210 METHOD USED : SIMULATED ANNEALING, TORSION REMARK 210 ANGLE DYNAMICS REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 48 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 10 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LOWEST REMARK 210 ENERGY,TARGET FUNCTION REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: STRUCTURE WAS DETERMINED BASED ON HOMONUCLEAR TOCSY/NOESY REMARK 210 TECHNIQUES USING AUTOMATIC ASSIGNMENT IN NOAH/DYANA PROGRAM REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 ARG A 15 78.26 -114.49 REMARK 500 2 PRO A 8 172.17 -53.95 REMARK 500 2 ARG A 15 53.83 -113.19 REMARK 500 2 CYS A 38 -167.72 -72.54 REMARK 500 2 ARG A 39 -25.03 -36.76 REMARK 500 2 ALA A 40 146.67 63.07 REMARK 500 2 LYS A 41 -166.98 -116.42 REMARK 500 3 CYS A 14 174.91 -54.44 REMARK 500 4 CYS A 38 75.16 -115.84 REMARK 500 4 ARG A 39 -20.11 85.23 REMARK 500 4 ALA A 40 159.79 62.94 REMARK 500 4 LYS A 41 -168.35 -114.61 REMARK 500 4 ASN A 43 59.71 -93.65 REMARK 500 4 ASN A 44 82.97 -151.77 REMARK 500 6 ILE A 19 86.02 -66.53 REMARK 500 6 ARG A 39 -23.80 83.06 REMARK 500 6 ALA A 40 164.27 58.47 REMARK 500 6 LYS A 41 -164.92 -116.58 REMARK 500 7 ILE A 19 85.60 -68.17 REMARK 500 7 ARG A 39 -33.86 80.80 REMARK 500 7 ALA A 40 169.30 50.06 REMARK 500 7 LYS A 41 -169.39 -128.49 REMARK 500 8 LEU A 6 33.61 -93.84 REMARK 500 8 CYS A 14 176.94 -59.18 REMARK 500 8 LYS A 41 -168.91 -104.30 REMARK 500 9 CYS A 14 174.73 -55.62 REMARK 500 9 ASN A 44 87.33 -150.52 REMARK 500 10 ARG A 15 50.75 -116.69 REMARK 500 REMARK 500 REMARK: NULL DBREF 1LD5 A 1 58 UNP P00974 BPT1_BOVIN 36 93 SEQADV 1LD5 ARG A 15 UNP P00974 LYS 50 CONFLICT SEQADV 1LD5 VAL A 16 UNP P00974 ALA 51 ENGINEERED MUTATION SEQADV 1LD5 LEU A 52 UNP P00974 MET 87 CONFLICT SEQRES 1 A 58 ARG PRO ASP PHE CYS LEU GLU PRO PRO TYR THR GLY PRO SEQRES 2 A 58 CYS ARG VAL ARG ILE ILE ARG TYR PHE TYR ASN ALA LYS SEQRES 3 A 58 ALA GLY LEU CYS GLN THR PHE VAL TYR GLY GLY CYS ARG SEQRES 4 A 58 ALA LYS ARG ASN ASN PHE LYS SER ALA GLU ASP CYS LEU SEQRES 5 A 58 ARG THR CYS GLY GLY ALA HELIX 1 1 PRO A 2 GLU A 7 5 6 HELIX 2 2 SER A 47 GLY A 56 1 10 SHEET 1 A 2 ILE A 18 TYR A 23 0 SHEET 2 A 2 CYS A 30 TYR A 35 -1 O TYR A 35 N ILE A 18 SSBOND 1 CYS A 5 CYS A 55 1555 1555 2.03 SSBOND 2 CYS A 14 CYS A 38 1555 1555 2.03 SSBOND 3 CYS A 30 CYS A 51 1555 1555 2.03 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000